These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10935239)

  • 41. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
    Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of gabapentin as an add-on therapy in refractory partial epileptic patients.
    Towanabut S; Rungreangyingyod L; Suthisisang C
    J Med Assoc Thai; 2001 Apr; 84(4):554-61. PubMed ID: 11460968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.
    Morrell MJ; McLean MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus L; Bernstein P; Rose-Legatt
    Seizure; 2000 Jun; 9(4):241-8. PubMed ID: 10880282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5.
    Neurology; 1993 Nov; 43(11):2292-8. PubMed ID: 8232945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
    Yamauchi T; Kaneko S; Yagi K; Sase S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study.
    Mattia D; Spanedda F; Bassetti MA; Romigi A; Placidi F; Marciani MG
    Clin Neurophysiol; 2000 Feb; 111(2):311-7. PubMed ID: 10680567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.
    Goa KL; Sorkin EM
    Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gabapentin associated with aggressive behavior in pediatric patients with seizures.
    Tallian KB; Nahata MC; Lo W; Tsao CY
    Epilepsia; 1996 May; 37(5):501-2. PubMed ID: 8617181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E
    Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Gabapentin (Neurontin): a new possibility in the add-on therapy of partial epilepsies].
    Krämer G
    Praxis (Bern 1994); 1996 Jan; 85(4):84-93. PubMed ID: 8578059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gabapentin.
    Chadwick D
    Epilepsy Res Suppl; 1991; 3():183-6. PubMed ID: 1777078
    [No Abstract]   [Full Text] [Related]  

  • 53. Gabapentin in generalized seizures.
    Chadwick D; Leiderman DB; Sauermann W; Alexander J; Garofalo E
    Epilepsy Res; 1996 Nov; 25(3):191-7. PubMed ID: 8956916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A beneficial effect on mood in partial epilepsy patients treated with gabapentin.
    Harden CL; Lazar LM; Pick LH; Nikolov B; Goldstein MA; Carson D; Ravdin LD; Kocsis JH; Labar DR
    Epilepsia; 1999 Aug; 40(8):1129-34. PubMed ID: 10448827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89.
    Bergey GK; Morris HH; Rosenfeld W; Blume WT; Penovich PE; Morrell MJ; Leiderman DB; Crockatt JG; LaMoreaux L; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):739-45. PubMed ID: 9305334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gabapentin.
    McLean MJ
    Epilepsia; 1995; 36 Suppl 2():S73-86. PubMed ID: 8784216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current data on gabapentin].
    Herranz JL
    Rev Neurol; 2000 Jun; 30 Suppl 1():S125-31. PubMed ID: 10904979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gabapentin--a new anticonvulsant.
    Med Lett Drugs Ther; 1994 Apr; 36(921):39-40. PubMed ID: 8159133
    [No Abstract]   [Full Text] [Related]  

  • 60. Gabapentin in the management of convulsive disorders.
    McLean MJ
    Epilepsia; 1999; 40 Suppl 6():S39-50; discussion S73-4. PubMed ID: 10530682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.